Log in

RBII RISING BIOSCIENCES INC OTC · United States

RISING BIOSCIENCES INC (RBII) news

RISING BIOSCIENCES INC is a public biotech or pharmaceutical company listed on OTC under the ticker RBII, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest RISING BIOSCIENCES INC news

We have not published a story on RISING BIOSCIENCES INC yet. When there is news, it will appear here.

Questions about RISING BIOSCIENCES INC

What is the ticker symbol of RISING BIOSCIENCES INC?

RISING BIOSCIENCES INC trades under the ticker RBII on OTC.

Where is RISING BIOSCIENCES INC listed?

RISING BIOSCIENCES INC is listed on OTC.

Which country or territory is RISING BIOSCIENCES INC listed under?

Our directory records RISING BIOSCIENCES INC under United States.

What does RISING BIOSCIENCES INC do?

Our directory classifies RISING BIOSCIENCES INC as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of RISING BIOSCIENCES INC?

The ISIN recorded for RISING BIOSCIENCES INC is US76761W1080.

Does aibio.space cover RISING BIOSCIENCES INC?

aibio.space lists RISING BIOSCIENCES INC among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to RISING BIOSCIENCES INC?

Companies in our directory listed in the same country and business area as RISING BIOSCIENCES INC: Braveheart Bio, Perrigo Company, Aligos Therapeutics, Keros Therapeutics, Protara Therapeutics, Pfizer.

Investor discussion: RISING BIOSCIENCES INC

Members talk about RISING BIOSCIENCES INC (RBII). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:RBII on TradingView.

Listing details

RISING BIOSCIENCES INC is a public biotech or pharmaceutical company listed on OTC under the ticker RBII, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
RISING BIOSCIENCES INC
Ticker
RBII
Listing
OTC
Country or territory
United States
Business scope
Pharmaceuticals: Major
ISIN
US76761W1080
Last quote in directory
2026-10-15
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.